122 related articles for article (PubMed ID: 17699278)
1. Mycophenolate mofetil for the treatment of interstitial nephritis.
Preddie DC; Markowitz GS; Radhakrishnan J; Nickolas TL; D'Agati VD; Schwimmer JA; Gardenswartz M; Rosen R; Appel GB
Clin J Am Soc Nephrol; 2006 Jul; 1(4):718-22. PubMed ID: 17699278
[TBL] [Abstract][Full Text] [Related]
2. Management of corticosteroid-dependent eosinophilic interstitial nephritis: A case report.
Tanabe K; Matsuoka-Uchiyama N; Mifune T; Kawakita C; Sugiyama H; Wada J
Medicine (Baltimore); 2021 Dec; 100(50):e28252. PubMed ID: 34918693
[TBL] [Abstract][Full Text] [Related]
3. Lupus nephritis: treatment with mycophenolate mofetil.
Kapitsinou PP; Boletis JN; Skopouli FN; Boki KA; Moutsopoulos HM
Rheumatology (Oxford); 2004 Mar; 43(3):377-80. PubMed ID: 14963204
[TBL] [Abstract][Full Text] [Related]
4. Mycophenolate mofetil treatment for therapy-resistant glomerulopathies.
Sahin GM; Sahin S; Kantarci G; Ergin H
Nephrology (Carlton); 2007 Jun; 12(3):285-8. PubMed ID: 17498124
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate mofetil for the treatment of refractory, acute, cellular renal transplant rejection. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Transplantation; 1996 Mar; 61(5):722-9. PubMed ID: 8607174
[TBL] [Abstract][Full Text] [Related]
6. Mycophenolate mofetil for the treatment of a first acute renal allograft rejection: The Mycophenolate Mofetil Acute Renal Rejection Study Group.
Transplantation; 1998 Jan; 65(2):235-41. PubMed ID: 9458021
[TBL] [Abstract][Full Text] [Related]
7. A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation. The Tricontinental Mycophenolate Mofetil Renal Transplantation Study Group.
Transplantation; 1996 Apr; 61(7):1029-37. PubMed ID: 8623181
[TBL] [Abstract][Full Text] [Related]
8. Mycophenolate mofetil therapy for children with lupus nephritis refractory to both intravenous cyclosphosphamide and cyclosporine.
Fu YF; Liu GL
Clin Nephrol; 2001 Apr; 55(4):318-21. PubMed ID: 11334319
[TBL] [Abstract][Full Text] [Related]
9. Idiopathic granulomatous interstitial nephritis responsive to mycophenolate mofetil therapy.
Leeaphorn N; Stokes MB; Ungprasert P; Lecates W
Am J Kidney Dis; 2014 Apr; 63(4):696-9. PubMed ID: 24315767
[TBL] [Abstract][Full Text] [Related]
10. Azithromycin-Induced, Biopsy-Proven Acute Interstitial Nephritis in an Adult Successfully Treated with Low-Dose Corticosteroids.
Woodruff AE; Meaney CJ; Hansen EA; Prescott GM
Pharmacotherapy; 2015 Nov; 35(11):e169-74. PubMed ID: 26598102
[TBL] [Abstract][Full Text] [Related]
11. [Mycophenolate mofetil in treatment of childhood nephrotic syndrome--preliminary report].
Kwinta-Rybicka J; Wilkosz K; Wierzchowska-Słowiacze EK; Ogarek I; Moczulska A; Stec Z; Pełkowska A; Sancewicz-Pach K; Pietrzyk JA
Przegl Lek; 2006; 63 Suppl 3():44-8. PubMed ID: 16898486
[TBL] [Abstract][Full Text] [Related]
12. Rescue therapy with mycophenolate mofetil. The Mycophenolate Mofetil Renal Refractory Rejection Study Group.
Clin Transplant; 1996 Feb; 10(1 Pt 2):131-5. PubMed ID: 8680050
[TBL] [Abstract][Full Text] [Related]
13. Mycophenolate mofetil treatment in primary glomerular disease: one-year follow-up in steroid dependent and resistant nephrotic syndrome.
Tasanarong A; Thitiarchakul S
J Med Assoc Thai; 2006 Aug; 89 Suppl 2():S218-27. PubMed ID: 17044475
[TBL] [Abstract][Full Text] [Related]
14. Reduction of proteinuria with mycophenolate mofetil in predominantly membranous lupus nephropathy.
Karim MY; Pisoni CN; Ferro L; Tungekar MF; Abbs IC; D'Cruz DP; Khamashta MA; Hughes GR
Rheumatology (Oxford); 2005 Oct; 44(10):1317-21. PubMed ID: 16049051
[TBL] [Abstract][Full Text] [Related]
15. Mycophenolate mofetil for remission induction in severe lupus nephritis.
Cross J; Dwomoa A; Andrews P; Burns A; Gordon C; Main J; Mathieson P; O'Donoghue D; Jayne D;
Nephron Clin Pract; 2005; 100(3):c92-100. PubMed ID: 15824513
[TBL] [Abstract][Full Text] [Related]
16. Mycophenolate mofetil for the treatment of scleritis.
Sen HN; Suhler EB; Al-Khatib SQ; Djalilian AR; Nussenblatt RB; Buggage RR
Ophthalmology; 2003 Sep; 110(9):1750-5. PubMed ID: 13129873
[TBL] [Abstract][Full Text] [Related]
17. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation.
Raimondo ML; Dagher L; Papatheodoridis GV; Rolando N; Patch DW; Davidson BR; Rolles K; Burroughs AK
Transplantation; 2003 Jan; 75(2):186-90. PubMed ID: 12548120
[TBL] [Abstract][Full Text] [Related]
18. [Mycophenolate mofetil in high risk IgA glomerulonephritis].
Frutos MA; López V; Alférez MJ; Aranda P
Nefrologia; 2005; 25(4):387-92. PubMed ID: 16231504
[TBL] [Abstract][Full Text] [Related]
19. Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.
Hu W; Liu Z; Chen H; Tang Z; Wang Q; Shen K; Li L
Chin Med J (Engl); 2002 May; 115(5):705-9. PubMed ID: 12133539
[TBL] [Abstract][Full Text] [Related]
20. Mycophenolate mofetil in autoimmune hepatitis patients not responsive or intolerant to standard immunosuppressive therapy.
Inductivo-Yu I; Adams A; Gish RG; Wakil A; Bzowej NH; Frederick RT; Bonacini M
Clin Gastroenterol Hepatol; 2007 Jul; 5(7):799-802. PubMed ID: 17509945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
